Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert J. Bitterman currently holds 411,421 shares of RXi Pharmaceuticals Corp (RXII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Bitterman has been a net buyer of RXII stock. They have purchased $44.0K and sold $0 worth of shares.
Robert J. Bitterman's most recent insider trade was on Feb 5, 2026, when they sold 120,000 shares at $0.00 per share.
Robert J. Bitterman serves as Executive at RXi Pharmaceuticals Corp (RXII). They have executed 36 insider transactions totaling $44.0K over their tenure at the company.
Robert J. Bitterman holds the position of Executive at RXi Pharmaceuticals Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Robert J. Bitterman has shown a buying trading pattern, with $44.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert J. Bitterman was on Nov 18, 2019, when they purchased $30.0K worth of PHIO shares. This transaction involved 300,000 shares at $0.10 per share.
Robert J. Bitterman currently owns 411,421 shares of RXi Pharmaceuticals Corp (RXII), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert J. Bitterman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert J. Bitterman has 36 Form 4 filings on record as an insider at RXi Pharmaceuticals Corp.
Set alerts for Robert J. Bitterman and 40,000+ other insiders.